Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Chairperson’s Remarks

• Jon A. Rowley, Ph.D., RoosterBio Inc.

Applications for Use of the Lovo Cell Processing System in Cell Therapy Process Development and Manufacturing

• Alaina C. Schlinker, Ph.D., Fresenius Kabi USA, LLC

TBA

• Philip G. Vanek, Ph.D., GE Healthcare

Platform Processes for PSC Derived Product Manufacture

• Nick Timmins

Building the 3rd Pillar of Medicine: Bioprocessing for Cell Therapies

• Steve K.W. Oh, Bioprocessing Technology Institute

Enabling Technologies for Efficient Downstream Processing of AAV Viral Vectors

• Orjana Terova, Purification, Thermo Fisher Scientific

Chairperson’s Remarks

• Dominic Clarke, Charter Medical

Innovative Device Development for Cell Therapies

• Jamie Piret, Sc.D., The University of British Columbia

Applying Single-Use Technologies

• Paula Alves, Ph.D., iBET, Portugal

Manufacturing Multiple Cell Based Products Simulaneously

• Gail K. Naughton, Ph.D., Histogen Inc.

Scale Out iPSC Derivation and Differentiation Processes for Cell Therapy

• Wen Bo Wang, Ph.D., Cellular Dynamics International, a FujiFilm company

SOURCE

https://lifesciences.knect365.com/cell-therapy-bioprocessing/agenda/3?stream=1